www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Glancy-Binkow-Goldberg-LLP-Representing-Investors-Who-Purchased-Cell-Therapeutics-Inc-Announces-Class-Action-Lawsuit-and-Seeks-to-Recover-Losses-760180 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Notice is hereby given that Glancy Binkow Goldberg LLP has filed a class action lawsuit ...http://www.finanzen.net/nachricht/Glancy-Binkow-Goldberg-LLP-Representing-Investors-Who-Purchased-Cell-Therapeutics-Inc-Announces-Class-Action-Lawsuit-and-Seeks-to-Recover-Losses-760180http://www.finanzen.net/nachricht/Glancy-Binkow-Goldberg-LLP-Representing-Investors-Who-Purchased-Fuqi-International-Inc-Announces-Class-Action-Lawsuit-and-Seeks-to-Recover-Losses-760179 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Notice is hereby given that Glancy Binkow Goldberg LLP has filed a class action lawsuit ...http://www.finanzen.net/nachricht/Glancy-Binkow-Goldberg-LLP-Representing-Investors-Who-Purchased-Fuqi-International-Inc-Announces-Class-Action-Lawsuit-and-Seeks-to-Recover-Losses-760179http://www.finanzen.net/nachricht/Robbins-Umeda-LLP-Announces-Investigation-of-Cell-Therapeutics-Inc-758183 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by certain officers ...http://www.finanzen.net/nachricht/Robbins-Umeda-LLP-Announces-Investigation-of-Cell-Therapeutics-Inc-758183http://www.finanzen.net/nachricht/Kendall-Law-Group-Plans-Class-Action-on-Behalf-of-Cell-Therapeutics-Inc-Shareholders-757513 Kendall Law Group announced today that it plans to join a lawsuit on behalf of shareholders of Cell Therapeutics, Inc. (NASDAQ:CTIC) alleging securities violations by <a href="/aktien/Cell_Therapeutics-Aktie">Cell Therapeutics</a> ...http://www.finanzen.net/nachricht/Kendall-Law-Group-Plans-Class-Action-on-Behalf-of-Cell-Therapeutics-Inc-Shareholders-757513http://www.finanzen.net/nachricht/Law-Offices-of-Howard-G-Smith-Announces-Class-Action-Lawsuit-Against-Cell-Therapeutics-Inc-756798 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Law Offices of Howard G. Smith announces that a securities class action lawsuit has ...http://www.finanzen.net/nachricht/Law-Offices-of-Howard-G-Smith-Announces-Class-Action-Lawsuit-Against-Cell-Therapeutics-Inc-756798http://www.finanzen.net/nachricht/Coughlin-Stoia-Geller-Rudman-Robbins-LLP-Files-Class-Action-Suit-Against-Cell-Therapeutics-Inc-756769 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Coughlin Stoia Geller Rudman Robbins LLP ("Coughlin Stoia”) (http://www.csgrr.com/cases/cellthera/) today announced that a class action has been ...http://www.finanzen.net/nachricht/Coughlin-Stoia-Geller-Rudman-Robbins-LLP-Files-Class-Action-Suit-Against-Cell-Therapeutics-Inc-756769http://www.finanzen.net/nachricht/Holzer-Holzer-Fistel-LLC-is-Investigating-Potential-Violations-of-Federal-Securities-Laws-by-Cell-Therapeutics-Inc-756195 Holzer Holzer Fistel, LLC is investigating potential violations of the federal securities laws by Cell Therapeutics, Inc. ("Cell Therapeutics” or the "Company”) (NASDAQ: CTIC). The investigation focuses on whether a ...http://www.finanzen.net/nachricht/Holzer-Holzer-Fistel-LLC-is-Investigating-Potential-Violations-of-Federal-Securities-Laws-by-Cell-Therapeutics-Inc-756195http://www.finanzen.net/nachricht/aktien/Wall-Street-Media-Presents-a-Video-of-Dr-James-Bianco-CEO-of-Cell-Therapeutics-Inc-Nasdaq-and-MTA-CTIC-303555Wall Street Media is presenting an exclusive highlight video from the presentation of Dr. James Bianco, CEO of Cell Therapeutics, Inc. (NASDAQ and MTA: CTIC) from the Invest Northwest(TM) Investor and CEO Forum on Tuesday, March 18, ...http://www.finanzen.net/nachricht/aktien/Wall-Street-Media-Presents-a-Video-of-Dr-James-Bianco-CEO-of-Cell-Therapeutics-Inc-Nasdaq-and-MTA-CTIC-303555http://www.finanzen.net/nachricht/Cell-Therapeutics-Umsatz-geht-um-ueber-80-Prozent-zurueck-75886 Das amerikanische Biopharma-Unternehmen Cell Therapeutics Inc. (CTI) (ISIN US1509341079/ WKN 906780) verbuchte im vierten Quartal 2005 einen herben R&uuml;ckgang bei Umsatz, konnte aber den Verlust reduzieren. Unternehmensangaben vom Dienstag zufolge ...http://www.finanzen.net/nachricht/Cell-Therapeutics-Umsatz-geht-um-ueber-80-Prozent-zurueck-75886http://www.finanzen.net/nachricht/Cell-Therapeutics-Umsatz-und-Verlust-sinken-leicht-43936 Das Biopharma-Unternehmen Cell Therapeutics Inc. (CTI) (ISIN US1509341079 / WKN 906780) verbuchte im zweiten Quartal 2005 einen leichten R&uuml;ckgang bei Umsatz und Verlust. Unternehmensangaben vom Dienstag zufolge sanken die Umsatzerl&ouml;se auf 7,5 ...http://www.finanzen.net/nachricht/Cell-Therapeutics-Umsatz-und-Verlust-sinken-leicht-43936